biotech · Alzheimer Disease · Friedreich Ataxia · LXEO
Lexeo Therapeutics
News and analysis for Lexeo Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.
New York, USA HQ
2018 Founded
91 Employees
Public company Type
LXEO · NYSE Ticker
Company details
- Status
- Public
- HQ
- New York, USA
- Founded
- 2018
- Employees
- 91
- Programs
- 3
- Drugs
- 4
- Patents
- 0
News & analysis
NovaPharmaNews articles mentioning Lexeo Therapeutics — regulatory, clinical, and market coverage.
News and analysis for Lexeo Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.